1. Home
  2. ACTU
  3. ACTU News

Latest ACTUATE THERAPEUTICS INC (ACTU) News on September 19, 2024

Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
ACTU

GlobeNewswire

3 days ago

Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research

Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
ACTU

GlobeNewswire

8 days ago

Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas

Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma
ACTU

GlobeNewswire

10 days ago

Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma

Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ACTU

GlobeNewswire

14 days ago

Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024
ACTU

GlobeNewswire

a month ago

Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024

Actuate Therapeutics Announces Closing of Initial Public Offering
ACTU

GlobeNewswire

a month ago

Actuate Therapeutics Announces Closing of Initial Public Offering

Share on Social Networks: